StockNews.com upgraded shares of Invitae (NYSE:NVTA – Free Report) from a sell rating to a hold rating in a research note published on Friday. Separately, The Goldman Sachs Group decreased their price target on Invitae from $1.00 to $0.50 and set a sell rating on the stock in a research note on Friday, October 20th. […]
Related Keywords
United States , Canada , , Goldman Sachs Group , Sg Americas Securities , Oppenheimer Co , Advisor Group , Invitae Corporation , Free Report , Get Free Report , Invitae Daily , Invitae , Nyse Nvta , Nvta , Medical , Upgrade , Stocknews Com ,
comparemela.com © 2020. All Rights Reserved.